Mylan Tenofovir/Lamivudine 300mg/300mg Tablets
Mylan Tenofovir/Lamivudine (300mg/300mg) is a fixed-dose combination antiretroviral medication used in the management of HIV-1 infection, Chronic Hepatitis B, and for Post-Exposure Prophylaxis (PEP). This product, manufactured by Mylan Laboratories (now part of Viatris), combines two powerful active ingredients: Tenofovir Disoproxil Fumarate (300mg) and Lamivudine (300mg).
Key Uses in Nigeria
In Nigeria, this dual-drug combination is widely recognized for its clinical versatility:
- HIV Treatment: It serves as a reliable backbone in antiretroviral therapy (ART) regimens.
- Post-Exposure Prophylaxis (PEP): It is a standard choice for individuals who may have been exposed to HIV, helping to prevent infection when started promptly.
- Hepatitis B Management: Effective in treating chronic Hepatitis B virus (HBV) infection.
How it Works
Both ingredients belong to a class of drugs known as Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs). They work by blocking the enzymes that the virus needs to replicate, thereby reducing the viral load in the body and supporting the immune system.
Dosage and Administration
Mylan Tenofovir/Lamivudine is typically taken as one tablet daily, or as directed by a healthcare professional. It is important to complete the full course as prescribed, especially when used for PEP. Consult a GoMed pharmacist or your doctor for specific guidance on how to use this medication.
Quality and Reliability
This product is NAFDAC registered (Reg No. A4-3126) and meets international quality standards. Mylan (Viatris) is a global leader in providing affordable and high-quality generic medications.